Neutropenia is an indicator of outcomes in metastatic colorectal cancer patients treated with FTD/TPI plus bevacizumab: a retrospective study
Yohei Nose, Yoshinori Kagawa, Taishi Hata, Ryota Mori, Kenji Kawai, Atsushi Naito, Takuya Sakamoto, Kohei Murakami, Yoshiteru Katsura, Yoshiaki Ohmura, Toru Masuzawa, Atsushi Takeno, Yutaka Takeda, Takeshi Kato, Kohei Murata
Topics & Concepts
MedicineBevacizumabInternal medicineNeutropeniaHazard ratioColorectal cancerOncologyChemotherapyCombination therapyProgression-free survivalGastroenterologyConfidence intervalRefractory (planetary science)Febrile neutropeniaCancerSurgeryAstrobiologyPhysicsColorectal Cancer Treatments and StudiesNeutropenia and Cancer InfectionsCancer Treatment and Pharmacology